{"count": 10, "results": [{"_id": "36267597", "pmid": 36267597, "pmcid": "PMC9577541", "title": "Metformin Decreases Serum Thyroglobulin Concentration in Nonmedullary Thyroid Carcinoma", "journal": "J Endocr Soc", "authors": ["Caetano C", "Pico PT", "Singh C", "Tendler B", "Malchoff DM", "Malchoff CD"], "date": "2022-09-13T00:00:00Z", "doi": "10.1210/jendso/bvac140", "meta_date_publication": "2022 Oct 11", "meta_volume": "6", "meta_issue": "11", "meta_pages": "bvac140", "score": 50282.31, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Decreases Serum @GENE_TG @GENE_7038 @@@Thyroglobulin@@@ Concentration in @<m>DISEASE_Thyroid_Cancer_Papillary</m> @DISEASE_MESH:D000077273 @@@Nonmedullary Thyroid Carcinoma@@@", "citations": {"NLM": "Caetano C, Pico PT, Singh C, Tendler B, Malchoff DM, Malchoff CD. Metformin Decreases Serum Thyroglobulin Concentration in Nonmedullary Thyroid Carcinoma J Endocr Soc. 2022 Oct 11;6(11):bvac140. PMID: 36267597", "BibTeX": "@article{36267597, title={Metformin Decreases Serum Thyroglobulin Concentration in Nonmedullary Thyroid Carcinoma}, author={Caetano C and Pico PT and Singh C and Tendler B and Malchoff DM and Malchoff CD}, journal={J Endocr Soc}, volume={6}, number={11}, pages={bvac140}}"}}, {"_id": "35050486", "pmid": 35050486, "title": "Metformin exerts an antitumoral effect on papillary thyroid cancer cells through altered cell energy metabolism and sensitized by BACH1 depletion.", "journal": "Endocrine", "authors": ["Yu Y", "Feng C", "Kuang J", "Guo L", "Guan H"], "date": "2022-04-01T00:00:00Z", "doi": "10.1007/s12020-021-02977-7", "meta_date_publication": "2022 Apr", "meta_volume": "76", "meta_issue": "1", "meta_pages": "116-131", "score": 50261.363, "text_hl": "The aims of this study were to investigate whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ exerts antitumor effects in @<m>DISEASE_Thyroid_Cancer_Papillary</m> @DISEASE_MESH:D000077273 @@@PTC@@@ cells and explore the role of @GENE_BACH1 @GENE_12013 @@@BACH1@@@ depletion on the sensitivity of @<m>DISEASE_Thyroid_Cancer_Papillary</m> @DISEASE_MESH:D000077273 @@@PTC@@@ cells to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Yu Y, Feng C, Kuang J, Guo L, Guan H. Metformin exerts an antitumoral effect on papillary thyroid cancer cells through altered cell energy metabolism and sensitized by BACH1 depletion. Endocrine. 2022 Apr;76(1):116-131. PMID: 35050486", "BibTeX": "@article{35050486, title={Metformin exerts an antitumoral effect on papillary thyroid cancer cells through altered cell energy metabolism and sensitized by BACH1 depletion.}, author={Yu Y and Feng C and Kuang J and Guo L and Guan H}, journal={Endocrine}, volume={76}, number={1}, pages={116-131}}"}}, {"_id": "36815657", "pmid": 36815657, "title": "Metformin and 2-Deoxy-d-glucose synergistically inhibit the viability of thyroid papillary carcinoma with BRAF mutation by ROS-dependent PI3K/AKT signaling pathway.", "journal": "Anticancer Agents Med Chem", "authors": ["Lin X", "Xu J", "Ma C", "Wang Z", "Yang X", "Song X", "Zheng H"], "date": "2023-02-23T00:00:00Z", "doi": "10.2174/1871520623666230223124733", "meta_date_publication": "2023 Feb 23", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50251.887, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2-Deoxy-d-glucose@@@ synergistically inhibit the viability of @<m>DISEASE_Thyroid_Cancer_Papillary</m> @DISEASE_MESH:D000077273 @@@thyroid papillary carcinoma@@@ with @GENE_BRAF @GENE_673 @@@BRAF@@@ mutation by @CHEMICAL_Reactive_Oxygen_Species @CHEMICAL_MESH:D017382 @@@ROS@@@-dependent PI3K/@GENE_AKT1 @GENE_207 @@@AKT@@@ signaling pathway.", "citations": {"NLM": "Lin X, Xu J, Ma C, Wang Z, Yang X, Song X, Zheng H. Metformin and 2-Deoxy-d-glucose synergistically inhibit the viability of thyroid papillary carcinoma with BRAF mutation by ROS-dependent PI3K/AKT signaling pathway. Anticancer Agents Med Chem. 2023 Feb 23;():. PMID: 36815657", "BibTeX": "@article{36815657, title={Metformin and 2-Deoxy-d-glucose synergistically inhibit the viability of thyroid papillary carcinoma with BRAF mutation by ROS-dependent PI3K/AKT signaling pathway.}, author={Lin X and Xu J and Ma C and Wang Z and Yang X and Song X and Zheng H}, journal={Anticancer Agents Med Chem}}"}}, {"_id": "40980146", "pmid": 40980146, "title": "Thyroid cancer: From molecular insights to therapy (Review).", "journal": "Oncol Lett", "authors": ["Li Z", "Wang N", "Li X", "Xie Y", "Dou Z", "Xin H", "Lin Y", "Si Y", "Feng T", "Wang G"], "date": "2025-09-10T00:00:00Z", "doi": "10.3892/ol.2025.15266", "meta_date_publication": "2025 Nov", "meta_volume": "30", "meta_issue": "5", "meta_pages": "520", "score": 50238.95, "text_hl": "Metabolic interventions, including @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ modulation in @<m>DISEASE_Thyroid_Cancer_Papillary</m> @DISEASE_MESH:D000077273 @@@PTC@@@ and novel delivery systems such as micelle-encapsulated AB3 for @DISEASE_Familial_medullary_thyroid_carcinoma @DISEASE_MESH:C536911 @@@MTC@@@, demonstrate translational potential. ", "citations": {"NLM": "Li Z, Wang N, Li X, Xie Y, Dou Z, Xin H, Lin Y, Si Y, Feng T, Wang G. Thyroid cancer: From molecular insights to therapy (Review). Oncol Lett. 2025 Nov;30(5):520. PMID: 40980146", "BibTeX": "@article{40980146, title={Thyroid cancer: From molecular insights to therapy (Review).}, author={Li Z and Wang N and Li X and Xie Y and Dou Z and Xin H and Lin Y and Si Y and Feng T and Wang G}, journal={Oncol Lett}, volume={30}, number={5}, pages={520}}"}}, {"_id": "24905037", "pmid": 24905037, "title": "Therapeutic potential of metformin in papillary thyroid cancer in vitro and in vivo.", "journal": "Mol Cell Endocrinol", "authors": ["Cho SW", "Yi KH", "Han SK", "Sun HJ", "Kim YA", "Oh BC", "Park YJ", "Park DJ"], "date": "2014-08-05T00:00:00Z", "doi": "10.1016/j.mce.2014.05.021", "meta_date_publication": "2014 Aug 5", "meta_volume": "393", "meta_issue": "1-2", "meta_pages": "24-9", "score": 50072.973, "text_hl": "Therapeutic potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Thyroid_Cancer_Papillary</m> @DISEASE_MESH:D000077273 @@@papillary thyroid cancer@@@ in vitro and in vivo.", "citations": {"NLM": "Cho SW, Yi KH, Han SK, Sun HJ, Kim YA, Oh BC, Park YJ, Park DJ. Therapeutic potential of metformin in papillary thyroid cancer in vitro and in vivo. Mol Cell Endocrinol. 2014 Aug 5;393(1-2):24-9. PMID: 24905037", "BibTeX": "@article{24905037, title={Therapeutic potential of metformin in papillary thyroid cancer in vitro and in vivo.}, author={Cho SW and Yi KH and Han SK and Sun HJ and Kim YA and Oh BC and Park YJ and Park DJ}, journal={Mol Cell Endocrinol}, volume={393}, number={1-2}, pages={24-9}}"}}, {"_id": "27920093", "pmid": 27920093, "title": "Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo.", "journal": "J Mol Endocrinol", "authors": ["Shen CT", "Wei WJ", "Qiu ZL", "Song HJ", "Zhang XY", "Sun ZK", "Luo QY"], "date": "2017-01-01T00:00:00Z", "doi": "10.1530/JME-16-0134", "meta_date_publication": "2017 Jan", "meta_volume": "58", "meta_issue": "1", "meta_pages": "15-23", "score": 50072.73, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reduces glycometabolism of @<m>DISEASE_Thyroid_Cancer_Papillary</m> @DISEASE_MESH:D000077273 @@@papillary thyroid carcinoma@@@ in vitro and in vivo.", "citations": {"NLM": "Shen CT, Wei WJ, Qiu ZL, Song HJ, Zhang XY, Sun ZK, Luo QY. Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo. J Mol Endocrinol. 2017 Jan;58(1):15-23. PMID: 27920093", "BibTeX": "@article{27920093, title={Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo.}, author={Shen CT and Wei WJ and Qiu ZL and Song HJ and Zhang XY and Sun ZK and Luo QY}, journal={J Mol Endocrinol}, volume={58}, number={1}, pages={15-23}}"}}, {"_id": "29798082", "pmid": 29798082, "title": "[Effects of metformin on papillary thyroid carcinoma in nude rats model].", "journal": "Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi", "authors": ["Dong LR", "Wang X", "Hu K", "Li S", "Xiong YJ", "Li M", "Tang H", "Liu AD", "Song XD"], "date": "2018-04-01T00:00:00Z", "doi": "10.13201/j.issn.1001-1781.2018.07.010", "meta_date_publication": "2018 Apr", "meta_volume": "32", "meta_issue": "7", "meta_pages": "518-521", "score": 50070.285, "text_hl": "[Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Thyroid_Cancer_Papillary</m> @DISEASE_MESH:D000077273 @@@papillary thyroid carcinoma@@@ in nude @SPECIES_10116 @@@rats@@@ model].", "citations": {"NLM": "Dong LR, Wang X, Hu K, Li S, Xiong YJ, Li M, Tang H, Liu AD, Song XD. [Effects of metformin on papillary thyroid carcinoma in nude rats model]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Apr;32(7):518-521. PMID: 29798082", "BibTeX": "@article{29798082, title={[Effects of metformin on papillary thyroid carcinoma in nude rats model].}, author={Dong LR and Wang X and Hu K and Li S and Xiong YJ and Li M and Tang H and Liu AD and Song XD}, journal={Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi}, volume={32}, number={7}, pages={518-521}}"}}, {"_id": "29798416", "pmid": 29798416, "title": "[Metformin induced apoptosis of papillary thyroid carcinoma BCPAP cells].", "journal": "Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi", "authors": ["Dong LR", "Li M", "Li S", "Liu AD", "Xiong YJ", "Tang H", "Song XD"], "date": "2017-06-20T00:00:00Z", "doi": "10.13201/j.issn.1001-1781.2017.12.010", "meta_date_publication": "2017 Jun 20", "meta_volume": "31", "meta_issue": "12", "meta_pages": "937-940", "score": 50068.11, "text_hl": "[@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ induced apoptosis of @<m>DISEASE_Thyroid_Cancer_Papillary</m> @DISEASE_MESH:D000077273 @@@papillary thyroid carcinoma@@@ @CELLLINE_CVCL:0153 @@@BCPAP@@@ cells].", "citations": {"NLM": "Dong LR, Li M, Li S, Liu AD, Xiong YJ, Tang H, Song XD. [Metformin induced apoptosis of papillary thyroid carcinoma BCPAP cells]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Jun 20;31(12):937-940. PMID: 29798416", "BibTeX": "@article{29798416, title={[Metformin induced apoptosis of papillary thyroid carcinoma BCPAP cells].}, author={Dong LR and Li M and Li S and Liu AD and Xiong YJ and Tang H and Song XD}, journal={Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi}, volume={31}, number={12}, pages={937-940}}"}}, {"_id": "15760778", "pmid": 15760778, "title": "Reversible renal insufficiency attributable to thyroid hormone withdrawal in a patient with type 2 diabetes mellitus.", "journal": "Endocr Pract", "authors": ["Bernet VJ"], "date": "2004-07-01T00:00:00Z", "doi": "10.4158/EP.10.4.339", "meta_date_publication": "2004 Jul-Aug", "meta_volume": "10", "meta_issue": "4", "meta_pages": "339-44", "score": 50046.145, "text_hl": "OBJECTIVE: To present a case of @<m>DISEASE_Thyroid_Cancer_Papillary</m> @DISEASE_MESH:D000077273 @@@papillary thyroid carcinoma@@@ and the need for follow-up surveillance in a @SPECIES_9606 @@@patient@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ who was being treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Bernet VJ. Reversible renal insufficiency attributable to thyroid hormone withdrawal in a patient with type 2 diabetes mellitus. Endocr Pract. 2004 Jul-Aug;10(4):339-44. PMID: 15760778", "BibTeX": "@article{15760778, title={Reversible renal insufficiency attributable to thyroid hormone withdrawal in a patient with type 2 diabetes mellitus.}, author={Bernet VJ}, journal={Endocr Pract}, volume={10}, number={4}, pages={339-44}}"}}, {"_id": "26284586", "pmid": 26284586, "pmcid": "PMC4741856", "title": "mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib", "journal": "Oncotarget", "authors": ["Hanly EK", "Bednarczyk RB", "Tuli NY", "Moscatello AL", "Halicka HD", "Li J", "Geliebter J", "Darzynkiewicz Z", "Tiwari RK"], "date": "2015-11-24T00:00:00Z", "doi": "10.18632/oncotarget.4052", "meta_date_publication": "2015 Nov 24", "meta_volume": "6", "meta_issue": "37", "meta_pages": "39702-13", "score": 50037.12, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ alone and the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-@CHEMICAL_Vemurafenib @CHEMICAL_MESH:D000077484 @@@vemurafenib@@@ combination treatment significantly decrease cell viability in @VARIANT_p.V600E_BRAF_human @VARIANT_tmVar:p|SUB|V|600|E;HGVS:p.V600E;VariantGroup:0;CorrespondingGene:673;RS#:113488022;CorrespondingSpecies:9606;CA#:123643 @@@BRAFV600E@@@-positive @<m>DISEASE_Thyroid_Cancer_Papillary</m> @DISEASE_MESH:D000077273 @@@papillary and anaplastic thyroid cancer@@@ cells", "citations": {"NLM": "Hanly EK, Bednarczyk RB, Tuli NY, Moscatello AL, Halicka HD, Li J, Geliebter J, Darzynkiewicz Z, Tiwari RK. mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib Oncotarget. 2015 Nov 24;6(37):39702-13. PMID: 26284586", "BibTeX": "@article{26284586, title={mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib}, author={Hanly EK and Bednarczyk RB and Tuli NY and Moscatello AL and Halicka HD and Li J and Geliebter J and Darzynkiewicz Z and Tiwari RK}, journal={Oncotarget}, volume={6}, number={37}, pages={39702-13}}"}}]}